STOCK TITAN

Inmed Pharmaceuticals Inc (INM) Net Income by Year

INM

Inmed Pharmaceuticals Inc reported a net loss of $8.2M in fiscal year 2025. This represents a decrease of 6.3% from the prior fiscal year. Over the trailing 12 months, Q4 FY2025 through Q3 FY2026, the same line adds up to a $8.5M net loss. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Inmed Pharmaceuticals Inc has filed alongside them.

FY2025 annual
Net Income -$8.2M
YoY -6.3%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Mar 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

INM Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY25S-4FY24S-4FY2310-KFY2210-KFY2110-KFY2010-K
Net Income-$8.5M-$8.2M-6.3%-$7.7M+3.4%-$7.9M+57.3%-$18.6M-82.3%-$10.2M-14.1%-$8.9M

TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.

INM Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'26S-4Q2'2610-QQ1'2610-QQ4'25S-4Q3'2510-QQ2'2510-QQ1'2510-QQ4'24S-4Q3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
Net Income-$3.0M-39.9%-$2.0M+21.2%-$1.7M-2.9%-$1.8M+7.7%-$2.1M-23.1%-$2.6M-74.2%-$1.7M+33.9%-$1.9M-472.6%-$1.7M+13.8%-$1.5M+29.6%-$2.5M+27.7%-$338K

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Inmed Pharmaceuticals Inc financials

Frequently Asked Questions

What was Inmed Pharmaceuticals Inc's net income in fiscal year 2025?

Inmed Pharmaceuticals Inc reported a net loss of $8.2M in fiscal year 2025.

How fast is Inmed Pharmaceuticals Inc's net income growing?

Inmed Pharmaceuticals Inc (INM) net income fell by 6.3% year over year, from -$7.7M to -$8.2M in fiscal year 2025.

What is Inmed Pharmaceuticals Inc's net income over the last twelve months?

Inmed Pharmaceuticals Inc (INM) reported a $8.5M net loss over the trailing 12 months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.

Across the 6 fiscal years this page covers, Inmed Pharmaceuticals Inc (INM) net income went from -$8.9M in fiscal year 2020 to -$8.2M in fiscal year 2025.

Inmed Pharmaceuticals Inc (INM) reported -$3.0M in net income in Q3 2026. This represents a decrease of 39.9% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Inmed Pharmaceuticals Inc (INM) reported on that line in every period on record.